BIOMAT Database Logo BIOMAT Database Logo

Effect of hormone replacement therapy on anti-thrombin III activity in post menopausal women. 1986

T R Varma, and R H Patel, and D Rosenberg

Anti-thrombin III is the major inhibitor of activated blood clotting factors. We studied 320 patients with climacteric symptoms who received estrogen replacement therapy to assess the effect of hormone therapy on Anti-thrombin III (AT-III) activity). Of the 320 patients 80 patients received Prempak C (0.625 mg) for 2 years, 82 patients received Prempak C (1.25 mg) for 2 years, 78 patients received Cycloprogynova (1 mg) for 2 years and the remaining 80 patients received Cycloprogynova (2 mg) for 2 years. The mean AT-III activity before, during and 3 months after treatment showed no significant difference in all the four groups of patients. There was no incidence of myocardial infarction or stroke or thrombo-embolic disease in this group of 320 patients receiving estrogen replacement therapy.

UI MeSH Term Description Entries
D008593 Menopause The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age. Change of Life, Female
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D004967 Estrogens Compounds that interact with ESTROGEN RECEPTORS in target tissues to bring about the effects similar to those of ESTRADIOL. Estrogens stimulate the female reproductive organs, and the development of secondary female SEX CHARACTERISTICS. Estrogenic chemicals include natural, synthetic, steroidal, or non-steroidal compounds. Estrogen,Estrogen Effect,Estrogen Effects,Estrogen Receptor Agonists,Estrogenic Agents,Estrogenic Compounds,Estrogenic Effect,Estrogenic Effects,Agents, Estrogenic,Agonists, Estrogen Receptor,Compounds, Estrogenic,Effects, Estrogen,Effects, Estrogenic,Receptor Agonists, Estrogen
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

T R Varma, and R H Patel, and D Rosenberg
Hormone replacement therapy in post-menopausal women.
January 1992, Adverse drug reactions and toxicological reviews,
T R Varma, and R H Patel, and D Rosenberg
Effect of hormone replacement therapy on hemostatic variables in post-menopausal women.
December 2005, Saudi medical journal,
T R Varma, and R H Patel, and D Rosenberg
The effect of hormone replacement therapy on cognitive function in post-menopausal women.
September 2007, QJM : monthly journal of the Association of Physicians,
T R Varma, and R H Patel, and D Rosenberg
Complications of hormone replacement therapy in post-menopausal women.
July 1992, Journal of the Royal Society of Medicine,
T R Varma, and R H Patel, and D Rosenberg
[Hormone replacement therapy on menopausal women].
November 1994, Nihon Ika Daigaku zasshi,
T R Varma, and R H Patel, and D Rosenberg
Immune effects of hormone replacement therapy in post-menopausal women.
February 2001, Experimental gerontology,
T R Varma, and R H Patel, and D Rosenberg
Ten years post-menopausal hormone replacement therapy--effect on lipoproteins.
April 1984, Maturitas,
T R Varma, and R H Patel, and D Rosenberg
Cardiovascular disease and hormone replacement therapy in post-menopausal women.
January 2006, Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners,
T R Varma, and R H Patel, and D Rosenberg
Dry eye in post-menopausal women using hormone replacement therapy.
March 2007, Maturitas,
T R Varma, and R H Patel, and D Rosenberg
[Hormone replacement therapy and urinary incontinence in post-menopausal women].
April 2011, Zhonghua fu chan ke za zhi,
Copied contents to your clipboard!